Immune thrombocytopenias. Hosp Pract (Off Ed) 1983 Nov;18(11):187-90, 194-5, 198-9 passim
Date
11/01/1983Pubmed ID
6414933DOI
10.1080/21548331.1983.11702692Scopus ID
2-s2.0-0020912447 (requires institutional sign-in at Scopus site)Abstract
The common denominator of this group of disorders is bleeding due to antibody-mediated platelet destruction. The variations in clinical manifestation--ranging from mild to fatal--reflect the diverse origins of the troublesome antibodies: transplacental, exogenous, and autogenous. Treatment--if necessary--may involve steroids, exchange transfusion, apheresis, or splenectomy.
Author List
Aster RHAuthor
Richard H. Aster MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antibody SpecificityAntigen-Antibody Reactions
Autoantibodies
Autoimmune Diseases
Blood Platelets
Female
HLA Antigens
Humans
Immune System Diseases
Infant, Newborn
Isoantigens
Platelet Transfusion
Purpura, Thrombocytopenic
Thrombocytopenia
Transfusion Reaction









